Subtopic Deep Dive

Nuclear Receptor Coactivator Recruitment
Research Guide

What is Nuclear Receptor Coactivator Recruitment?

Nuclear Receptor Coactivator Recruitment is the ligand-induced binding of coactivators via LXXLL motifs to the AF-2 domain of activated nuclear receptors to initiate transcription.

This process involves specific interactions between the helical LXXLL motifs of p160 coactivators like SRC1 and the coactivator-binding cleft in the ligand-binding domain of nuclear receptors (Chang et al., 1999; 363 citations). Research dissects selectivity determinants using combinatorial peptide libraries and identifies distinct binding regions for AF1 and AF2 domains (Bevan et al., 1999; 419 citations). Over 10 key papers from 1997-2012 detail mechanisms, with foundational works exceeding 400 citations each.

15
Curated Papers
3
Key Challenges

Why It Matters

Coactivator recruitment modulates steroid receptor partial agonist activity, explaining why antagonists like tamoxifen exhibit tissue-specific agonist effects through hinge domain coactivators L7/SPA and corepressors N-CoR/SMRT (Jackson et al., 1997; 463 citations). This selectivity influences therapeutic outcomes in breast cancer and endocrine disorders. Targeting LXXLL interactions offers strategies for metabolic diseases, as seen in CAR receptor agonism by xenobiotics regulating CYP enzyme expression (Tzameli et al., 2000; 412 citations).

Key Research Challenges

Coregulator Selectivity Determinants

Nuclear receptors exhibit differential recruitment of SRC1 regions by AF1 versus AF2 domains, complicating predictions of coactivator specificity (Bevan et al., 1999). Combinatorial peptide libraries reveal LXXLL sequence variations but lack structural dynamics (Chang et al., 1999). Over 400-citation papers highlight unresolved binding affinity hierarchies.

Partial Agonist Coactivator Access

Antagonist-occupied receptors paradoxically recruit coactivators via novel hinge-binding L7/SPA, controlled by N-CoR/SMRT ratios (Jackson et al., 1997; 463 citations). This tissue-specific agonism challenges drug design for tamoxifen-like compounds. Mechanisms remain debated across 400+ citation works.

Ligand-Dependent Conformational Switching

Agonist binding exposes the AF-2 cleft for LXXLL docking, but xenobiotic ligands like TCPOBOP induce atypical recruitment on CAR (Tzameli et al., 2000). Structural intermediates evade capture in high-citation studies (Robinson-Rechavi et al., 2003; 583 citations). Dynamic modeling gaps persist.

Essential Papers

1.

Dopamine as a Prolactin (PRL) Inhibitor

Nira Ben‐Jonathan, Robert Hnasko · 2001 · Endocrine Reviews · 933 citations

Dopamine is a small and relatively simple molecule that fulfills diverse functions. Within the brain, it acts as a classical neurotransmitter whose attenuation or overactivity can result in disorde...

2.

The nuclear receptor superfamily

Marc Robinson‐Rechavi, Héctor Escrivá, Vincent Laudet · 2003 · Journal of Cell Science · 583 citations

Nuclear receptors are one of the most abundant classes of transcriptional regulators in animals (metazoans). They regulate diverse functions, such as homeostasis, reproduction, development and meta...

3.

The Cyclic AMP Pathway

Paolo Sassone‐Corsi · 2012 · Cold Spring Harbor Perspectives in Biology · 512 citations

cAMP was the first second messenger to be identified. Its three main effectors are PKA (which phosphorylates numerous metabolic enzymes), EPAC (a guanine-nucleotide-exchange factor), and cyclic-nuc...

4.

The Partial Agonist Activity of Antagonist-Occupied Steroid Receptors Is Controlled by a Novel Hinge Domain-Binding Coactivator L7/SPA and the Corepressors N-CoR or SMRT

Twila A. Jackson, Jennifer K. Richer, David L. Bain et al. · 1997 · Molecular Endocrinology · 463 citations

Steroid receptor antagonists, such as the antiestrogen tamoxifen or the antiprogestin RU486, can have inappropriate agonist-like effects in tissues and tumors. To explain this paradox we postulated...

5.

cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia

Haitao Wang, Jiangping Xu, Philip Lazarovici et al. · 2018 · Frontiers in Molecular Neuroscience · 426 citations

Dopamine is a brain neurotransmitter involved in the pathology of schizophrenia. The dopamine hypothesis states that, in schizophrenia, dopaminergic signal transduction is hyperactive. The cAMP-res...

6.

The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

Charlotte L. Bevan, Sue Hoare, Frank Claessens et al. · 1999 · Molecular and Cellular Biology · 419 citations

The androgen receptor is unusual among nuclear receptors in that most, if not all, of its activity is mediated via the constitutive activation function in the N terminus. Here we demonstrate that p...

7.

The Xenobiotic Compound 1,4-Bis[2-(3,5-Dichloropyridyloxy)]Benzene Is an Agonist Ligand for the Nuclear Receptor CAR

Iphigenia Tzameli, Pavlos Pissios, Erin G. Schuetz et al. · 2000 · Molecular and Cellular Biology · 412 citations

A wide range of xenobiotic compounds are metabolized by cytochrome P450 (CYP) enzymes, and the genes that encode these enzymes are often induced in the presence of such compounds. Here, we show tha...

Reading Guide

Foundational Papers

Start with Jackson et al. (1997; 463 citations) for partial agonist paradox via L7/SPA, then Bevan et al. (1999; 419 citations) for AF1/AF2-SRC1 mapping, and Chang et al. (1999; 363 citations) for LXXLL library methods—these establish core mechanisms with >1,200 combined citations.

Recent Advances

Study Tzameli et al. (2000; 412 citations) on CAR xenobiotic agonism and Robinson-Rechavi et al. (2003; 583 citations) for superfamily context to bridge to modern selectivity research.

Core Methods

Combinatorial peptide phage display (Chang et al., 1999); co-immunoprecipitation and deletion mapping (Bevan et al., 1999); coactivator swap assays with N-CoR/SMRT (Jackson et al., 1997).

How PapersFlow Helps You Research Nuclear Receptor Coactivator Recruitment

Discover & Search

Research Agent uses citationGraph on Jackson et al. (1997; 463 citations) to map coactivator papers, revealing clusters around L7/SPA and N-CoR/SMRT, then exaSearch for 'LXXLL AF-2 selectivity' retrieves 50+ related works including Bevan et al. (1999). findSimilarPapers expands to SRC1 domain interactions from Chang et al. (1999).

Analyze & Verify

Analysis Agent applies readPaperContent to parse Bevan et al. (1999) SRC1 binding data, then runPythonAnalysis with pandas to quantify AF1/AF2 interaction strengths from tables, verified by verifyResponse (CoVe) and GRADE scoring for evidence strength in motif selectivity claims.

Synthesize & Write

Synthesis Agent detects gaps in partial agonist mechanisms by flagging underexplored L7/SPA interactions across Jackson et al. (1997) and Tzameli et al. (2000), then Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to generate a review figure with exportMermaid diagrams of recruitment cascades.

Use Cases

"Extract binding affinity data from SRC1 AF1/AF2 papers and plot Kd values"

Research Agent → searchPapers('SRC1 AF1 AF2') → Analysis Agent → readPaperContent(Bevan 1999) → runPythonAnalysis(pandas plot Kd) → matplotlib affinity graph output.

"Write LaTeX review on LXXLL motif selectivity with citations"

Synthesis Agent → gap detection(LXXLL Chang 1999) → Writing Agent → latexEditText(intro) → latexSyncCitations(Jackson 1997, Bevan 1999) → latexCompile → PDF review output.

"Find GitHub repos analyzing nuclear receptor docking simulations"

Research Agent → searchPapers('LXXLL docking') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → curated code list for AF-2 simulations.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ coactivator papers starting with citationGraph on Robinson-Rechavi et al. (2003), producing structured report on superfamily recruitment patterns. DeepScan applies 7-step analysis with CoVe checkpoints to verify LXXLL selectivity claims from Chang et al. (1999). Theorizer generates hypotheses on hinge domain L7/SPA evolution from Jackson et al. (1997) literature synthesis.

Frequently Asked Questions

What defines nuclear receptor coactivator recruitment?

It is the agonist-induced exposure of the AF-2 coactivator cleft for LXXLL motif binding, enabling p160 coactivators like SRC1 to drive transcription (Chang et al., 1999; Bevan et al., 1999).

What methods study LXXLL interactions?

Combinatorial peptide libraries identify antagonists (Chang et al., 1999; 363 citations); co-IP and mapping dissect AF1/AF2-SRC1 contacts (Bevan et al., 1999; 419 citations).

What are key papers on this topic?

Foundational: Jackson et al. (1997; 463 citations) on partial agonists; Bevan et al. (1999; 419 citations) on AR-SRC1; Chang et al. (1999; 363 citations) on LXXLL libraries.

What open problems exist?

Unresolved tissue-specific coactivator switching in partial agonists (Jackson et al., 1997); dynamic AF-2 cleft fluctuations; xenobiotic-induced atypical recruitment (Tzameli et al., 2000).

Research Receptor Mechanisms and Signaling with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Nuclear Receptor Coactivator Recruitment with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.